WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareMedical Instruments & Supplies
Best Medical Stocks to Buy Now (2022)
Top medical stocks in 2022 ranked by overall Zen Score. See the best medical stocks to buy now, according to analyst forecasts for the medical instruments & supplies industry.

Industry: Medical Instruments & Sup...
Ticker
Company
Forecast Score
Market Cap
Price
Price Target
Upside/Downside
Consensus
Analysts
Fore. Revenue Growth
Fore. Earnings Growth
Forecast ROE
Forecast ROA
STAA
STAAR SURGICAL CO
$2.85B$59.13$94.7560.24%Strong Buy918.75%31.50%38.10%30.90%
RMD
RESMED INC
$33.59B$229.34$263.8015.03%Buy88.21%16.77%36.70%24.33%
WST
WEST PHARMACEUTICAL SERVICES INC
$17.92B$242.02$283.3317.07%Buy36.28%8.51%37.63%28.03%
RGEN
REPLIGEN CORP
$10.45B$188.17$249.5032.59%Strong Buy49.60%12.00%14.67%10.94%
UTMD
UTAH MEDICAL PRODUCTS INC
$331.56M$91.40N/AN/AN/AN/AN/AN/AN/AN/A
ALC
ALCON INC
$34.45B$70.07$82.5017.74%Buy73.76%39.25%9.66%6.83%
POAI
PREDICTIVE ONCOLOGY INC
$37.41M$0.48$5.00952.63%Strong Buy2231.95%N/A93.14%83.11%
RVP
RETRACTABLE TECHNOLOGIES INC
$69.50M$2.11N/AN/AN/AN/AN/AN/AN/AN/A
MMSI
MERIT MEDICAL SYSTEMS INC
$4.13B$72.52$69.33-4.39%Strong Buy32.33%59.85%16.31%10.88%
MASI
MASIMO CORP
$7.66B$145.74$172.8318.59%Strong Buy615.93%28.35%24.97%10.23%
ZTEK
ZENTEK LTD
$193.10M$1.94$3.5080.41%Strong Buy1N/AN/AN/AN/A
BLFS
BIOLIFE SOLUTIONS INC
$935.29M$21.87$32.6749.37%Strong Buy315.38%N/A20.85%17.45%
EKSO
EKSO BIONICS HOLDINGS INC
$16.03M$1.22$9.00637.70%Buy137.69%N/A8.73%6.35%
ECOR
ELECTROCORE INC
$25.91M$0.36$2.75655.49%Buy144.31%N/A-35.26%-26.55%
HOLX
HOLOGIC INC
$18.93B$76.99$77.921.20%Buy13-2.64%-0.98%27.43%14.74%
HAE
HAEMONETICS CORP
$4.30B$84.88$96.1713.30%Buy73.36%28.24%25.06%9.80%
TFX
TELEFLEX INC
$11.48B$244.80$278.2113.65%Buy153.80%20.93%20.89%12.04%
ISRG
INTUITIVE SURGICAL INC
$97.00B$274.49$262.00-4.55%Strong Buy166.89%7.39%15.53%13.48%
ATRI
ATRION CORP
$1.11B$626.00N/AN/AN/AN/AN/AN/AN/AN/A
LMAT
LEMAITRE VASCULAR INC
$1.04B$47.42N/AN/AHold14.93%14.80%13.73%11.87%
FEMY
FEMASYS INC
$14.29M$1.21$7.33506.03%Strong Buy348.13%N/A-38.05%-34.20%
COO
COOPER COMPANIES INC
$16.12B$326.62$395.7121.15%Strong Buy107.50%28.06%12.79%7.84%
NEPH
NEPHROS INC
$10.80M$1.05$5.13389.49%Strong Buy36.30%N/A-31.10%-17.29%
ANGO
ANGIODYNAMICS INC
$497.84M$12.73$25.0096.39%Strong Buy17.39%N/A2.46%1.82%
BDX
BECTON DICKINSON & CO
$71.08B$250.83$264.635.50%Buy84.85%36.13%17.15%8.19%
NURO
NEUROMETRIX INC
$12.88M$1.66N/AN/AStrong Buy1N/AN/AN/AN/A
ATRC
ATRICURE INC
$2.14B$45.96$61.8334.54%Strong Buy612.00%N/A-5.37%-4.16%
PLSE
PULSE BIOSCIENCES INC
$71.85M$1.93$12.00521.76%Buy3107.16%N/A-360.91%-25.51%
NXGL
NEXGEL INC
$6.52M$1.17$6.00412.82%Strong Buy1N/AN/AN/AN/A
PDEX
PRO DEX INC
$61.97M$17.31N/AN/AN/AN/AN/AN/AN/AN/A
OMIC
SINGULAR GENOMICS SYSTEMS INC
$139.94M$1.96$3.5078.57%Hold3N/AN/A-31.97%-25.63%
STVN
STEVANATO GROUP SPA
$4.72B$15.97$23.4046.52%Strong Buy57.08%3.61%18.53%10.96%
SMTI
SANARA MEDTECH INC
$310.56M$37.40$50.0033.69%Strong Buy1N/AN/A2.01%1.49%
MHUA
MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES CO LTD
$337.75M$13.51N/AN/AN/AN/AN/AN/AN/AN/A
NVST
ENVISTA HOLDINGS CORP
$5.74B$35.20$46.6032.39%Strong Buy55.53%15.98%11.16%6.89%
AKYA
AKOYA BIOSCIENCES INC
$508.61M$13.40$17.0026.87%Strong Buy415.60%N/A-44.48%-18.93%
ISR
ISORAY INC
$54.29M$0.38N/AN/AN/AN/AN/AN/AN/AN/A
KRMD
KORU MEDICAL SYSTEMS INC
$138.56M$3.06$3.7522.55%Strong Buy29.96%N/AN/AN/A
OSUR
ORASURE TECHNOLOGIES INC
$371.82M$5.12$10.0095.31%Strong Buy1-12.19%N/A-9.98%-7.90%
IRTC
IRHYTHM TECHNOLOGIES INC
$3.26B$108.37$155.3043.31%Strong Buy1017.11%N/A-8.06%-4.38%
ICUI
ICU MEDICAL INC
$3.90B$162.70$225.0038.29%Buy28.20%N/A11.94%5.40%
MLSS
MILESTONE SCIENTIFIC INC
$41.18M$0.59N/AN/AN/AN/AN/AN/AN/AN/A
HBIO
HARVARD BIOSCIENCE INC
$115.39M$2.77$5.0080.51%Strong Buy18.73%N/AN/AN/A
XRAY
DENTSPLY SIRONA INC
$6.76B$31.44$49.4457.26%Buy103.27%N/A19.87%9.54%
WRBY
WARBY PARKER INC
$1.98B$17.16$21.8827.48%Buy816.83%N/A9.37%4.83%
NVCR
NOVOCURE LTD
$8.56B$81.54$109.8334.70%Buy86.93%N/A-16.02%-6.08%
NYXH
NYXOAH SA
$131.70M$5.11$21.33317.48%Buy3N/AN/A-17.83%-14.46%
LUCY
INNOVATIVE EYEWEAR INC
$9.13M$1.25N/AN/AN/AN/AN/AN/AN/AN/A
STE
STERIS PLC
$19.20B$192.31$240.0024.80%Strong Buy46.13%N/A18.15%10.04%
STSS
SHARPS TECHNOLOGY INC
$12.61M$1.34N/AN/AN/AN/AN/AN/AN/AN/A
GKOS
GLAUKOS CORP
$2.32B$48.66$57.7518.68%Buy99.71%N/A-3.30%-1.80%
MYMD
MYMD PHARMACEUTICALS INC
$82.49M$2.09N/AN/AN/AN/AN/AN/AN/AN/A
GCTK
GLUCOTRACK INC
$26.00M$1.68N/AN/AN/AN/AN/AN/AN/AN/A
MBOT
MICROBOT MEDICAL INC
$36.22M$4.59$20.00335.73%Strong Buy1N/AN/A-218.19%-162.95%
GMVD
G MEDICAL INNOVATIONS HOLDINGS LTD
$2.40M$3.45$6.0073.91%Strong Buy1N/AN/AN/AN/A
INFU
INFUSYSTEM HOLDINGS INC
$181.78M$8.80N/AN/AN/AN/AN/AN/AN/AN/A
BAX
BAXTER INTERNATIONAL INC
$26.41B$52.38$74.5842.39%Strong Buy123.54%N/A45.81%9.07%
BLCO
BAUSCH & LOMB CORP
$5.42B$15.49$21.2036.86%Buy10N/AN/A8.06%5.07%

Medical Stocks FAQ

What are the best medical stocks to buy right now in Dec 2022?

According to Zen Score, the 3 best medical stocks to buy right now are:

1. Staar Surgical Co (NASDAQ:STAA)


Staar Surgical Co (NASDAQ:STAA) is the top medical stock with a Zen Score of 72, which is 39 points higher than the medical industry average of 33. It passed 24 out of 33 due diligence checks and has strong fundamentals. Staar Surgical Co has seen its stock lose -34.25% over the past year, underperforming other medical stocks by -14 percentage points.

Staar Surgical Co has an average 1 year price target of $94.75, an upside of 60.24% from Staar Surgical Co's current stock price of $59.13.

Staar Surgical Co stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 9 analysts covering Staar Surgical Co, 88.89% have issued a Strong Buy rating, 11.11% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Resmed (NYSE:RMD)


Resmed (NYSE:RMD) is the second best medical stock with a Zen Score of 55, which is 22 points higher than the medical industry average of 33. It passed 21 out of 38 due diligence checks and has strong fundamentals. Resmed has seen its stock lose -9.46% over the past year, overperforming other medical stocks by 11 percentage points.

Resmed has an average 1 year price target of $263.80, an upside of 15.03% from Resmed's current stock price of $229.34.

Resmed stock has a consensus Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Resmed, 37.5% have issued a Strong Buy rating, 25% have issued a Buy, 37.5% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. West Pharmaceutical Services (NYSE:WST)


West Pharmaceutical Services (NYSE:WST) is the third best medical stock with a Zen Score of 53, which is 20 points higher than the medical industry average of 33. It passed 20 out of 38 due diligence checks and has strong fundamentals. West Pharmaceutical Services has seen its stock lose -44.42% over the past year, underperforming other medical stocks by -24 percentage points.

West Pharmaceutical Services has an average 1 year price target of $283.33, an upside of 17.07% from West Pharmaceutical Services's current stock price of $242.02.

West Pharmaceutical Services stock has a consensus Buy recommendation according to Wall Street analysts. Of the 3 analysts covering West Pharmaceutical Services, 33.33% have issued a Strong Buy rating, 0% have issued a Buy, 66.67% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the medical stocks with highest dividends?

Out of 11 medical stocks that have issued dividends in the past year, the 3 medical stocks with the highest dividend yields are:

1. Utah Medical Products (NASDAQ:UTMD)


Utah Medical Products (NASDAQ:UTMD) has an annual dividend yield of 3.14%, which is 2 percentage points higher than the medical industry average of 1.2%. Utah Medical Products's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Utah Medical Products's dividend has shown consistent growth over the last 10 years.

Utah Medical Products's dividend payout ratio of 65.1% indicates that its dividend yield is sustainable for the long-term.

2. Baxter International (NYSE:BAX)


Baxter International (NYSE:BAX) has an annual dividend yield of 2.2%, which is 1 percentage points higher than the medical industry average of 1.2%. Baxter International's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Baxter International's dividend has not shown consistent growth over the last 10 years.

Baxter International's dividend payout ratio of -24.2% indicates that its dividend yield might not be sustainable for the long-term.

3. Dentsply Sirona (NASDAQ:XRAY)


Dentsply Sirona (NASDAQ:XRAY) has an annual dividend yield of 1.54%, which is the same as the medical industry average of 1.2%. Dentsply Sirona's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Dentsply Sirona's dividend has shown consistent growth over the last 10 years.

Dentsply Sirona's dividend payout ratio of -12.7% indicates that its dividend yield might not be sustainable for the long-term.

Why are medical stocks up?

Medical stocks were up 2.28% in the last day, and up 3.77% over the last week.

We couldn't find a catalyst for why medical stocks are up.

What are the most undervalued medical stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued medical stocks right now are:

1. Retractable Technologies (NYSEMKT:RVP)


Retractable Technologies (NYSEMKT:RVP) is the most undervalued medical stock based on WallStreetZen's Valuation Score. Retractable Technologies has a valuation score of 71, which is 43 points higher than the medical industry average of 28. It passed 5 out of 7 valuation due diligence checks.

Retractable Technologies's stock has dropped -74.76% in the past year. It has underperformed other stocks in the medical industry by -54 percentage points.

2. Zentek (NASDAQ:ZTEK)


Zentek (NASDAQ:ZTEK) is the second most undervalued medical stock based on WallStreetZen's Valuation Score. Zentek has a valuation score of 71, which is 43 points higher than the medical industry average of 28. It passed 5 out of 7 valuation due diligence checks.

3. Utah Medical Products (NASDAQ:UTMD)


Utah Medical Products (NASDAQ:UTMD) is the third most undervalued medical stock based on WallStreetZen's Valuation Score. Utah Medical Products has a valuation score of 57, which is 29 points higher than the medical industry average of 28. It passed 4 out of 7 valuation due diligence checks.

Utah Medical Products's stock has dropped -20.29% in the past year. It has performed in line with other stocks in the medical industry.

Are medical stocks a good buy now?

58.7% of medical stocks rated by analysts are a strong buy right now. On average, analysts expect medical stocks to rise by 22.82% over the next year.

What is the average p/e ratio of the medical instruments & supplies industry?

The average P/E ratio of the medical instruments & supplies industry is -71.88x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.